In vivo and in vitro evidence for impaired arginine transport in human heart failure.

Kaye, D M; Ahlers, B A; Autelitano, D J; Chin-Dusting, J P

Kaye, D M; Ahlers, B A; Autelitano, D J; Chin-Dusting, J P.

Affiliation

Kaye DM; Baker Medical Research Institute and Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia. david.kaye@baker.edu.au

Circulation ; 102(22): 2707-12, 2000 Nov 28.

Article in En | MEDLINE | ID: mdl-11094036

Subject(s)

Arginine/pharmacokinetics; Heart Failure/drug therapy; Adult; Amino Acid Transport Systems, Basic; Arginine/blood; Biological Transport; Carrier Proteins/genetics; Forearm/blood supply; Gene Expression Regulation/drug effects; Heart Failure/physiopathology; Humans; Leukocytes, Mononuclear/cytology; Leukocytes, Mononuclear/drug effects; Leukocytes, Mononuclear/metabolism; Membrane Proteins/genetics; Middle Aged; RNA, Messenger/drug effects; RNA, Messenger/genetics; RNA, Messenger/metabolism; Regional Blood Flow/drug effects; Time Factors; Tritium

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arginine / Heart Failure Type of study: Clinical_trials Limits: Adult / Humans / Middle aged Language: En Journal: Circulation Year: 2000 Type: Article Affiliation country: Australia

Search on Google

XML

PubMed Links